Anavenol

Anavenol may be available in the countries listed below.

Ingredient matches for Anavenol

Dihydroergocristine

Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Anavenol in the following countries:

• Georgia

International Drug Name Search

Glifage

Glifage may be available in the countries listed below.

Ingredient matches for Glifage

Metformin

Metformin is reported as an ingredient of Glifage in the following countries:

• Brazil

International Drug Name Search

Genkova

Genkova may be available in the countries listed below.

Ingredient matches for Genkova

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Genkova in the following countries:

• Mexico

International Drug Name Search

Pryde MPS

Pryde MPS may be available in the countries listed below.

Ingredient matches for Pryde MPS

Cisapride

Cisapride is reported as an ingredient of Pryde MPS in the following countries:

• India

Dimeticone

Dimeticone is reported as an ingredient of Pryde MPS in the following countries:

• India

International Drug Name Search

Galastat

Galastat may be available in the countries listed below.

Ingredient matches for Galastat

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Galastat in the following countries:

• Serbia

International Drug Name Search

Buscopan plus Paracetamol

Buscopan plus Paracetamol may be available in the countries listed below.

Ingredient matches for Buscopan plus Paracetamol

Paracetamol

Paracetamol is reported as an ingredient of Buscopan plus Paracetamol in the following countries:

• Austria

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Buscopan plus Paracetamol in the following countries:

• Austria

International Drug Name Search

Aphthasol

Aphthasol is a brand name of amlexanox topical, approved by the FDA in the following formulation(s):

APHTHASOL (amlexanox - paste; dental)

• 
  Manufacturer: ULURU
  
  Approval date: December 17, 1996
  
  Strength(s): 5% ^[RLD]

Has a generic version of Aphthasol been approved?

No. There is currently no therapeutically equivalent version of Aphthasol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aphthasol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Methods of treating aphthous ulcers and other mucocutaneous disorders with amlexanox
  Patent 5,362,737
  Issued: November 8, 1994
  Inventor(s): Vora; Kakubhai R. & Khandwala; Atul & Smith; Charles G.
  Assignee(s): Chemex Pharmaceuticals, Inc.
  A method of treating aphthous ulcers and other mucocutaneous disorders is disclosed. The method comprises contacting the mucocutaneous disorder with a composition in the form of a paste, solution, gel, quick-disintegrating tablet, mouthwash, ointment, cream, powder, adhesive patch, aerosolized spray, lozenge, troche, dentifrice, or dental floss that contains an effective amount of an active compound of the formula: ##STR1## wherein R.sub.1 is hydrogen, alkyl, phenyl, carboxyl, hydroxyl, alkoxy, carboxyalkyl (i.e. esters), cyano, acylamino, or amino group which may be unsubstituted or substituted by up to two alkyl groups; m is 0, 1 or 2 and R.sub.2 is alkyl, alkenyl, alkoxy, halgoen, nitro, hydroxy, carboxyl, butadienylene (--CH.dbd.CH--CH.dbd.CH--) which forms a benzene ring with any adjacent carbon atoms, cyano, carboxyalkyl, trifluoromethyl, or amino group which may be unsubstituted or substituted by at least one alkyl; and R.sub.3 is carboxyl, cyano, arylalkoxycarbonyl, alkoxycarbonyl, or carboxamide which may be unsubstituted or substituted by at least one alkyl, and the salts thereof.
  
  Patent expiration dates:
  
  
  • November 8, 2011
    
    ✓ 
    Patent use: TOPICAL ADMINISTRATION
  
  

See also...

• Aphthasol Consumer Information (Drugs.com)
• Aphthasol Consumer Information (Wolters Kluwer)
• Aphthasol topical Consumer Information (Cerner Multum)
• Aphthasol Advanced Consumer Information (Micromedex)
• Aphthasol AHFS DI Monographs (ASHP)
• OraDisc A Consumer Information (Drugs.com)
• Amlexanox Consumer Information (Wolters Kluwer)
• Amlexanox topical Consumer Information (Cerner Multum)
• Amlexanox Mucous membrane, oral Advanced Consumer Information (Micromedex)
• Amlexanox AHFS DI Monographs (ASHP)